IHS Chemical Week

Regions :: India/Pakistan

FDA bans imports of Sun Pharma's products from plant in India

4:56 AM MDT | March 13, 2014 | Natasha Alperowicz

The FDA has imposed a ban on imports from Sun Pharma’s (Mumbai) Karkhadi, Gujarat plant in India. The facility makes APIs and formulations.  The FDA has issued an import alert on the plant. The ban is the latest in a series of FDA clampdowns on Indian drug makers. It follows FDA’s ban on all Ranbaxy Laboratories plants in India over production quality lapses.   India is a leading drug exporter to the United States, supplying about 40% of generic and over-the-counter drugs. The ban on the Sun Pharma unit indicates that it has not met cGMP...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa